Inflation directly affects the prices of prescription drugs in the U.S., but the Inflation Reduction Act can help combat the soaring prices and make them accessible to patients. According to a 2022 survey , one in three adults says they haven’t taken prescription medications due to the...

It’s natural for pregnant mothers to worry about their safety and that of their unborn child, and this may be even more true for women living with chronic conditions. However, there are steps you can take to reduce risk. Key Takeaways Every pregnant woman wants a safe and healthy...

Epidiolex (cannabidiol) is the first medication based on a purified drug substance, cannabidiol (CBD), derived from marijuana to gain approval from the US Food and Drug Administration (FDA). The drug is indicated for patients aged two years and older with Lennox-Gastaut syndrome or Dravet...

The US Food and Drug Administration (FDA) has granted approval to Gilenya (fingolimod) as a treatment for children and adolescents with multiple sclerosis (MS). The Novartis medication is the first drug approved by the FDA for treatment of pediatric patients with MS.  Gilenya first gained FDA...

Over the course of 2017, the number of approvals granted by the US Food and Drug Administration (FDA) reached a 21-year high. More than 1,000 generic drugs were approved by the agency, according to FDA Commissioner Scott Gottlieb, MD, while first-time generic drug approvals numbered 74. Novel drug...

A new drug to treat adult patients suffering from primary progressive multiple sclerosis (PPMS) has been approved by the US Food & Drug Administration (FDA). Ocrevus (ocrelizumab) was developed by Genentech - a member of the Roche Group - and will be available to patients across the United...